These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30804787)

  • 1. Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats.
    Bali ZK; Bruszt N; Tadepalli SA; Csurgyók R; Nagy LV; Tompa M; Hernádi I
    Front Pharmacol; 2019; 10():73. PubMed ID: 30804787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of cognitive enhancer effects of Alzheimer's disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task.
    Bruszt N; Bali ZK; Tadepalli SA; Nagy LV; Hernádi I
    Psychopharmacology (Berl); 2021 Nov; 238(11):3273-3281. PubMed ID: 34387707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of α7 nicotinic receptor agonist PHA-543613 on spatial memory performance of rats in two distinct pharmacological dementia models.
    Bali ZK; Inkeller J; Csurgyók R; Bruszt N; Horváth H; Hernádi I
    Behav Brain Res; 2015 Feb; 278():404-10. PubMed ID: 25447295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.
    Nikiforuk A; Potasiewicz A; Kos T; Popik P
    Behav Brain Res; 2016 Oct; 313():214-218. PubMed ID: 27435422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.
    Potasiewicz A; Krawczyk M; Gzielo K; Popik P; Nikiforuk A
    Behav Brain Res; 2020 May; 385():112547. PubMed ID: 32087183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
    Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
    Boess FG; de Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; König G
    Psychopharmacology (Berl); 2013 May; 227(1):1-17. PubMed ID: 23241647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo.
    Bali ZK; Nagy LV; Budai D; Hernádi I
    Sci Rep; 2019 Jun; 9(1):9324. PubMed ID: 31249369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals.
    Callahan PM; Bertrand D; Bertrand S; Plagenhoef MR; Terry AV
    Neuropharmacology; 2017 May; 117():422-433. PubMed ID: 28259598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.
    Pandya AA; Yakel JL
    Neuropharmacology; 2013 Jul; 70():35-42. PubMed ID: 23321689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive improvements in a rat model with polyunsaturated fatty acids EPA and DHA through α7-nicotinic acetylcholine receptors.
    Carlos DH; Bibiana Roselly CR; Angel UL; Laura MA; Kenya Karina SR; Jose Manuel CB; Alejandra CS; Gabriela CCE; Estefanía OR; Aracely SM
    Nutr Neurosci; 2022 Apr; 25(4):791-800. PubMed ID: 32840165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
    Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
    ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.
    Bitner RS; Bunnelle WH; Anderson DJ; Briggs CA; Buccafusco J; Curzon P; Decker MW; Frost JM; Gronlien JH; Gubbins E; Li J; Malysz J; Markosyan S; Marsh K; Meyer MD; Nikkel AL; Radek RJ; Robb HM; Timmermann D; Sullivan JP; Gopalakrishnan M
    J Neurosci; 2007 Sep; 27(39):10578-87. PubMed ID: 17898229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
    J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
    Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
    Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.